BioCentury
ARTICLE | Company News

Chromos, MorphoGen stem cell deal

April 24, 2002 7:00 AM UTC

Chromos (TSE:CHR) will use adult-derived stem cells from MorphoGen (San Diego, Calif.) for use in its cell-mediated gene therapy programs. CHR will study whether engineered chromosomes are transferrab...